☆ 4.7 Letter

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

ANNALS OF THE RHEUMATIC DISEASES (2021)

期刊

ANNALS OF THE RHEUMATIC DISEASES

卷 80, 期 10, 页码 1365-1366

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2021-221145

关键词

-

类别

Rheumatology

资金

Ben-Dov family
National Institute of Diabetes and Digestive and Kidney Diseases [F32DK124941, K01DK101677, K23DK115908]
National Institute of Allergy and Infectious Diseases [K24AI144954]
National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23AR073927]

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Infectious Diseases

SARS-CoV-2 antibody response in SARS survivors with and without the COVID-19 vaccine

Chang-Sheng Xia, Minghua Zhan, Yudong Liu, Zhi-Hong Yue, Ying Song, Feifei Zhang, Hui Wang

Summary: This study assessed the levels of protective antibodies in SARS survivors with and without the COVID-19 vaccine, and found that SARS survivors have protective antibodies against SARS-CoV-2 even without vaccination, and generate a stronger antibody response after vaccination compared to controls.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

添加到收藏夹

Article Immunology

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants

Gabriele Anichini, Chiara Terrosi, Gianni Gori Savellini, Claudia Gandolfo, Federico Franchi, Maria Grazia Cusi

Summary: The study found that healthy individuals vaccinated with the Comirnaty vaccine had significantly lower neutralizing antibody titers against the B.1.351 lineage, suggesting potential differences in protection levels among different SARS-CoV-2 lineages. No significant differences in neutralizing antibody titers were observed for the other two lineages.

VACCINES (2021)

添加到收藏夹

Article Immunology

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals

Daniele Lapa, Daria M. Grousova, Giulia Matusali, Silvia Meschi, Francesca Colavita, Aurora Bettini, Giulia Gramigna, Massimo Francalancia, Anna Rosa Garbuglia, Enrico Girardi, Vincenzo Puro, Andrea Antinori, Anna Kovyrshina, Inna Dolzhikova, Dmitry Shcheblyakov, Amir Tukhvatulin, Olga Zubkova, Vladimir A. Gushchin, Denis Y. Logunov, Boris S. Naroditsky, Francesco Vaia, Alexander L. Gintsburg

Summary: The Omicron variant of SARS-CoV-2 is rapidly spreading worldwide and has become dominant, leading to varying degrees of decreased neutralizing antibodies in vaccinated and infected individuals, highlighting the necessity of a third booster vaccination.

VACCINES (2022)

添加到收藏夹

Article Medicine, General & Internal

Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal-A Multicenter, Nationwide Study

Ana Rita Cruz-Machado, Sofia C. Barreira, Matilde Bandeira, Marc Veldhoen, Andreia Gomes, Marta Serrano, Catarina Duarte, Maria Rato, Bruno Miguel Fernandes, Salome Garcia, Filipe Pinheiro, Miguel Bernardes, Nathalie Madeira, Claudia Miguel, Rita Torres, Ana Bento Silva, Jorge Pestana, Diogo Almeida, Carolina Mazeda, Filipe Cunha Santos, Patricia Pinto, Marlene Sousa, Hugo Parente, Graca Sequeira, Maria Jose Santos, Joao Eurico Fonseca, Vasco C. Romao

Summary: The study found that patients treated with TNF inhibitors and tocilizumab had reduced risk of SARS-CoV-2 infection, while older age, comorbidities, and rituximab were associated with increased risk of infection and worse prognosis. Most patients with inflammatory RMDs developed a robust antibody response after COVID-19.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Immunology

Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines

Ping Li, Dawei Shi, Wenlong Shen, Shu Shi, Xinjie Guo, Jia Li, Sihong Xu, Yan Zhang, Zhihu Zhao

Summary: This study conducted a genome-wide association study in recipients of SARS-CoV-2 vaccines, identifying 177 SNPs and 41 independent loci associated with antibody levels. Specifically, the intronic variant rs4543780 of the FAM89A gene was found to be associated with total antibody levels and potentially affecting gene expression, with FAM89A being a biomarker for differentiating bacterial and viral infections.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Humoral immune response to COVID-19 mRNA vaccination in relation to selenium status

Kamil Demircan, Thilo Samson Chillon, Qian Sun, Raban Arved Heller, Georg Jochen Klingenberg, Ines Maria Hirschbil-Bremer, Petra Seemann, Joachim Diegmann, Manuel Bachmann, Arash Moghaddam, Lutz Schomburg

Summary: This observational study found no association between selenium status or supplemental selenium intake and humoral immune response to COVID-19 mRNA vaccination.

REDOX BIOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Humoral response to two doses of BNT162b2 vaccination in people with HIV

Line Dam Heftdal, Andreas Dehlbaek Knudsen, Sebastian Rask Hamm, Cecilie Bo Hansen, Dina Leth Moller, Mia Pries-Heje, Kamille Fogh, Rasmus Bo Hasselbalch, Ida Jarlhelt, Laura Perez-Alos, Linda Maria Hilsted, Sisse Rye Ostrowski, Jan Gerstoft, Kirsten Gronbaek, Henning Bundgaard, Kasper Iversen, Peter Garred, Susanne Dam Nielsen

Summary: This study found reduced IgG antibody response to the BNT162b2 vaccine in people with HIV, highlighting the need for increased awareness of breakthrough infections in this population.

JOURNAL OF INTERNAL MEDICINE (2022)

添加到收藏夹

Review Immunology

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans

Sicong Yu, Keda Che, Lei Fang, Haiyan Mao, Xiuyu Lou, Chaonan Li, Yanjun Zhang

Summary: SARS-CoV-2, MERS-CoV, and SARS-CoV pose a great threat to humanity, and the development of vaccines is crucial in combating these coronaviruses. Different types of vaccines are being researched and developed, with studies on neutralizing antibodies helping to evaluate and analyze the effectiveness of the vaccines.

VACCINES (2021)

添加到收藏夹

Article Cell Biology

Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases

Jonathan D. Herman, Caroline Atyeo, Yonatan Zur, Claire E. Cook, Naomi J. Patel, Kathleen M. Vanni, Emily N. Kowalski, Grace Qian, Shruthi Srivatsan, Nancy A. Shadick, Deepak A. Rao, Benjamin Kellman, Colin J. Mann, Douglas Lauffenburger, Zachary S. Wallace, Jeffrey A. Sparks, Galit Alter

Summary: Alterations in humoral immunity, including weaker binding of anti-SARS-CoV-2 antibodies and stronger binding of antibodies against endemic coronavirus OC43, were observed in individuals with PASC. Previous coronavirus imprinting may serve as a potential marker for the development of PASC.

SCIENCE TRANSLATIONAL MEDICINE (2023)

添加到收藏夹

Article Immunology

Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects

Jiaqi Zhang, Shan Xing, Dan Liang, Wei Hu, Changwen Ke, Jinyong He, Runyu Yuan, Yile Huang, Yizhe Li, Dongdong Liu, Xuedong Zhang, Lin Li, Jianhua Lin, Weili Li, Xiangyun Teng, Yijun Liu, Wei Wen, Qiang Kang, Dawei Wang, Wanli Liu, Jianhua Xu

Summary: A study showed that 90.7% of vaccinated individuals had NAb seroconversion, with all participants who seroconverted after the first dose being females with relatively high prevaccine estradiol levels. Individuals without seroconversion tended to have lower lymphocyte counts and higher serum SAA levels. Additionally, young vaccine recipients had significantly higher peak NAb titers compared to elderly recipients.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Association between a low response to rubella vaccination and reduced anti-severe acute respiratory syndrome coronavirus 2 immune response after vaccination with BNT162b2: a cross-sectional study

Kazuhiko Nakaharai, Yasushi Nakazawa, Yukie Mishima, Mari Saito, Yoichi Shinozaki, Masaki Yoshida

Summary: This study aimed to determine whether mRNA SARS-CoV-2 vaccination could induce a sufficient immune response against SARS-CoV-2 in low responders to other vaccinations. The results showed that individuals with low responses to measles, rubella, and HBV vaccinations had significantly reduced levels of anti-SARS-CoV-2 antibodies after receiving two doses of the BNT162b2 vaccine.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

添加到收藏夹

Article Immunology

Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab

Victoria Furer, Tali Eviatar, Devy Zisman, Hagit Peleg, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Daphna Paran, David Levartovsky, Michael Zisapel, Ofir Elalouf, Ilana Kaufman, Adi Broyde, Ari Polachek, Joy Feld, Amir Haddad, Tal Gazitt, Muna Elias, Nizar Higazi, Fadi Kharouf, Sara Pel, Sharon Nevo, Ori Elkayam

Summary: In patients with autoimmune inflammatory rheumatic diseases (AIIRD) treated with rituximab (RTX), the predictors of a positive immunogenic response to the BNT162b2 mRNA vaccine include the number of RTX courses, cumulative RTX dose, IgG level prior to last RTX course, and interval between RTX treatment and vaccination. ANCA-associated vasculitis and inflammatory myositis patients have a low likelihood of a seropositive immunogenic response.

VACCINES (2022)

添加到收藏夹

Article Rheumatology

Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide setting

Amir Bieber, Shay Brikman, Lena Novack, Ran Abuhasira, Abdallah Fawaz, Mahmoud Abu-Shakra, Lior Zeller, Eduard Ling, Reuven Mader, Iftach Sagy

Summary: This study aimed to evaluate the need for a fourth COVID-19 vaccination in patients with autoimmune rheumatic diseases. The analysis found that patients who received the fourth dose of the vaccine had a lower risk of COVID-19 infection, hospitalization, and death compared to those who had not been infected with COVID-19 and received three doses of the vaccine.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients

Daniel Honfi, Nikolett Gemes, Eniko Szabo, Patricia Neuperger, Jozsef A. Balog, Lajos Nagy, Gergely Toldi, Laszlo G. Puskas, Gabor J. Szebeni, Attila Balog

Summary: Vaccination against SARS-CoV-2 is highly recommended for immunocompromised patients with autoimmune rheumatic and musculoskeletal diseases (aiRMDs). This study found that patients receiving heterologous boosters showed better antibody levels and immune cell responses. Biologic therapy and disease duration may affect the specific immunity against SARS-CoV-2 in aiRMDs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Immunology

Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination

Furong Qi, Yingyin Cao, Shuye Zhang, Zheng Zhang

Summary: Vaccination and early therapeutic interventions are crucial in combating COVID-19, while single-cell multi-omic technologies can provide insights into the immune responses and molecular mechanisms associated with SARS-CoV-2 infection, aiding in the development of vaccines and therapeutics.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients

Andrew H. Karaba, Weiqiang Zhou, Shuai Li, Tihitina Y. Aytenfisu, Trevor S. Johnston, Olivia Akinde, Yolanda Eby, Aura T. Abedon, Jennifer L. Alejo, Caroline X. Qin, Elizabeth A. Thompson, Jacqueline M. Garonzik-Wang, Joel N. Blankson, Andrea L. Cox, Justin R. Bailey, Sabra L. Klein, Andrew Pekosz, Dorry L. Segev, Aaron A. R. Tobian, William A. Werbel

Summary: Antibody response to SARS-CoV-2 vaccination is reduced in solid organ transplant recipients (SOTRs), possibly due to increased levels of preexisting antibodies to seasonal coronaviruses, suggesting the influence of antigenic imprinting on vaccine responses in SOTRs.

CLINICAL INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Immunology

PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection

Sami Alasfar, Teresa Po-Yu Chiang, Andrew J. Snyder, Michael T. Ou, Brian J. Boyarsky, Aura T. Abedon, Jennifer L. Alejo, Sydney Cook, Willa Cochran, Emily Brigham, Ann M. Parker, Jacqueline Garonzik-Wang, Allan B. Massie, Daniel C. Brennan, Tracy Vannorsdall, Dorry L. Segev, Robin K. Avery

Summary: This study aimed to estimate the frequency of postacute sequelae of SARS-CoV-2 infection (PASC) symptoms in solid organ transplant (SOT) recipients and compared their frequency between those with hospitalized and non-hospitalized cases. The results showed a high frequency of PASC symptoms in SOT recipients, indicating the need for multidisciplinary care beyond the acute phase.

TRANSPLANTATION (2023)

添加到收藏夹

Article Surgery

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

Andrew H. Karaba, Jake D. Kim, Teresa P. -Y. Chiang, Jennifer L. Alejo, Ioannis Sitaras, Aura T. Abedon, Yolanda Eby, Trevor Scott Johnston, Maggie Li, Tihitina Ayten, Casey Hussey, Alexa Jefferis, Nicole Fortune, Rivka Abedon, Letitia Thomas, Feben Habtehyimer, Jessica Ruff, Daniel S. Warren, Robin K. Avery, William A. Clarke, Andrew Pekosz, Allan B. Massie, Aaron A. R. Tobian, Dorry L. Segev, William A. Werbel

Summary: Neutralizing antibody (nAb) responses are weakened in solid organ transplant recipients (SOTRs) despite being fully vaccinated. Preexposure prophylaxis (PrEP) with the antibody combination tixagevimab and cilgavimab (T+C) may enhance immune protection, but its activity and durability against Omicron sublineages BA.4/5 in fully vaccinated SOTRs have not been determined. Most fully vaccinated SOTRs receiving T+C PrEP achieved neutralization against BA.4/5, but nAb activity commonly declined after 3 months. It is crucial to evaluate the optimal dose and interval of T+C PrEP to maximize protection against emerging variants.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

添加到收藏夹

Article Surgery

Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk

Jennifer L. Alejo, Jake D. Kim, Teresa P. Y. Chiang, Robin K. Avery, Andrew H. Karaba, Alexa Jefferis, Daniel S. Warren, Allan B. Massie, Aaron A. R. Tobian, Dorry L. Segev, William A. Werbel

Summary: This study investigated the patient-reported outcomes of solid organ transplant recipients receiving T+C for COVID-19 prophylaxis. It found that T+C was well tolerated with few serious events. It also revealed changes in risk tolerance and reported breakthrough COVID-19 cases among recipients. These results contribute to counseling SOTRs on the real-world safety and effectiveness of T+C.

CLINICAL TRANSPLANTATION (2023)

添加到收藏夹

Letter Surgery

6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipients

Jonathan Mitchell, Teresa P. Y. Chiang, Jennifer L. Alejo, Jake D. Kim, Amy Chang, Aura T. Abedon, Robin K. Avery, Aaron A. R. Tobian, Macey L. Levan, Daniel S. Warren, Jacqueline M. Garonzik-Wang, Dorry L. Segev, Allan B. Massie, William A. Werbel

CLINICAL TRANSPLANTATION (2023)

添加到收藏夹

Letter Surgery

Letter to the editor: hook (prozone) effect in sars-cov-2 anti-spike binding antibody levels following vaccination, infection, or monoclonal antibody in solid organ transplant recipients

Aura T. Abedon, Teresa P. Y. Chiang, Andrew H. Karaba, Jennifer L. Alejo, Margaret Chahoud, Casey Hussey, Jessica F. Lopes, Sarah Hussain, Christian P. Larsen, Christine M. Durand, Peter S. Heeger, Dorry L. Segev, William A. Clarke, William A. Werbel

CLINICAL TRANSPLANTATION (2023)

添加到收藏夹

Editorial Material Medicine, General & Internal

Periorbital Edema in Dermatomyositis

Caoilfhionn M. Connolly, Lisa Christopher-Stine

Summary: A 61-year-old woman presented with periorbital edema and shoulder weakness lasting for 6 months. Physical examination revealed erythema of the upper and lower eyelids and significant periorbital swelling.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Letter Rheumatology

Bullous periorbital oedema in anti-p155/140-positive dermatomyositis: a case series

Caoilfhionn M. Connolly, Lillian Xu, Christopher A. Mecoli, Brittany L. Adler, Eleni Tiniakou, Jemima Albayda, Lisa Christopher-Stine, Julie J. Paik

RHEUMATOLOGY (2023)

添加到收藏夹

Article Immunology

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics

Nitipong Permpalung, Teresa Po-Yu Chiang, Robin K. Avery, Darin Ostrander, Kausik Datta, Dorry L. Segev, Christine M. Durand, Sean X. Zhang, Allan B. Massie, Kieren A. Marr

Summary: A retrospective study was conducted to investigate COVID-19-associated pulmonary aspergillosis (CAPA), which is likely underdiagnosed and lacks sensitive diagnostic tools. A CAPA prediction model was built using multivariable logistic regression analysis, and the performance of the model was assessed using the area under the receiver operating characteristic curve (AUC). The model identified several factors, such as age, intubation time, dexamethasone treatment, and underlying diseases, that were significantly associated with CAPA, resulting in an AUC of 0.75. Screening at a cutoff of =0.085, the model showed a sensitivity of 82%, specificity of 51%, positive predictive value of 18.6%, and negative predictive value of 95.3%.

OPEN FORUM INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipients

Elizabeth A. Thompson, Wabathi Ngecu, Laila Stoddart, Trevor S. Johnston, Amy Chang, Katherine Cascino, Jennifer L. Alejo, Aura T. Abedon, Hady Samaha, Nadine Rouphael, Aaron A. R. Tobian, Dorry L. Segev, William A. Werbel, Andrew H. Karaba, Joel N. Blankson, Andrea L. Cox

Summary: The SARS-CoV-2 Omicron BA.5 subvariant evades vaccination-induced neutralizing antibodies due to mutations in the spike protein. Solid organ transplant recipients (SOTRs) have poor recognition of the Omicron variant after COVID-19 vaccination. T cell responses are important for defense against the virus.

JCI INSIGHT (2023)

添加到收藏夹

Letter Rheumatology

Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with Tixagevimab plus Cilgavimab in vaccinated patients with autoimmune disease

C. M. Connolly, A. H. Karaba, T. Po-yu Chiang, M. Teles, J. D. Kim, T. Scott Johnson, J. L. Alejo, D. l. Segev, L. Christoher-Stine, W. A. Werbel, J. J. Paik

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

添加到收藏夹

Meeting Abstract Rheumatology

HUMORAL RESPONSE TO 3RD DOSE SARS-COV-2 VACCINE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES

Caoilfhionn M. Connolly, Teresa Po-Yu Chiang, Mayan Teles, Jennifer L. Alejo, Christopher A. Mecoli, Eleni Tiniakou, Brittany L. Adler, Jemima Albayda, William A. Werbel, Lisa Christopher-Stine, Dorry L. Segev, Julie J. Paik

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

添加到收藏夹

Letter Medicine, General & Internal

Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial

Niraj M. Desai, Sherry G. Leung, Jennifer D. Motter, Dorry L. Segev, Daniel Warren, Christine M. Durand

ANNALS OF INTERNAL MEDICINE (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.